Global fund financing to the 34 malaria-eliminating countries under the new funding model 2014–2017: an analysis of national allocations and regional grants

Table 5 Regional Grants for malaria under the NFM

GFATM regional grant for malaria	Total grant amount	Total estimated to malaria-eliminating countries included in grant scope	Malaria-eliminating countries included in regional grant scope
Elimination 8 (E8)	$17,800,000	$8,900,000	Botswana, Namibia, Swaziland, South Africa
Elimination of Malaria in Mesoamerica and the Island of Hispaniola (EMMIE)	$10,000,000	$5,666,668	Belize, Costa Rica, Dominican Republic, El Salvador, Nicaragua, and Panama
Regional Artemisinin-resistance Initiative (RAI)	$100,000,000	$25,000,000	Thailand and Vietnam

The E8 is not structured such that it has country specific breakdowns of funding. For this analysis, it was assumed that the US$17.8 million is divided equally among the eight countries (Angola, Botswana, Mozambique, Namibia, South Africa, Swaziland, Zambia and Zimbabwe)
The US$10 million EMMIE regional grant covers ten countries, five of which are eligible for startup funding (Costa Rica, Belize, El Salvador, Mexico, Panama), and nine of which are eligible for payouts (all but Mexico). EMMIE is a cash-on-delivery model and of the US$10 million, US$3 million will go to Population Services International as the Principal Recipient. Because it will not be known which countries will be successful in meeting targets until the end of years 2 and 3, this analysis assumed that the remaining amount (US$7 million) was evenly split over the nine eligible countries and added to startup funding, if applicable
Fifteen percent of the US$100 million RAI regional grant goes to Vietnam and 10 % goes to Thailand

ISSN: 1475-2875